Oxidative stress induces mitochondrial iron overload and ferroptotic cell death. 2023

Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
Department of Physiology and Biophysics, School of Medicine, University of Washington, 1705 NE Pacific Street, G424, Box 357290, Seattle, WA, 98195-7290, USA.

Oxidative stress has been shown to induce cell death in a wide range of human diseases including cardiac ischemia/reperfusion injury, drug induced cardiotoxicity, and heart failure. However, the mechanism of cell death induced by oxidative stress remains incompletely understood. Here we provide new evidence that oxidative stress primarily induces ferroptosis, but not apoptosis, necroptosis, or mitochondria-mediated necrosis, in cardiomyocytes. Intriguingly, oxidative stress induced by organic oxidants such as tert-butyl hydroperoxide (tBHP) and cumene hydroperoxide (CHP), but not hydrogen peroxide (H2O2), promoted glutathione depletion and glutathione peroxidase 4 (GPX4) degradation in cardiomyocytes, leading to increased lipid peroxidation. Moreover, elevated oxidative stress is also linked to labile iron overload through downregulation of the transcription suppressor BTB and CNC homology 1 (Bach1), upregulation of heme oxygenase 1 (HO-1) expression, and enhanced iron release via heme degradation. Strikingly, oxidative stress also promoted HO-1 translocation to mitochondria, leading to mitochondrial iron overload and lipid reactive oxygen species (ROS) accumulation. Targeted inhibition of mitochondrial iron overload or ROS accumulation, by overexpressing mitochondrial ferritin (FTMT) or mitochondrial catalase (mCAT), respectively, markedly inhibited oxidative stress-induced ferroptosis. The levels of mitochondrial iron and lipid peroxides were also markedly increased in cardiomyocytes subjected to simulated ischemia and reperfusion (sI/R) or the chemotherapeutic agent doxorubicin (DOX). Overexpressing FTMT or mCAT effectively prevented cardiomyocyte death induced by sI/R or DOX. Taken together, oxidative stress induced by organic oxidants but not H2O2 primarily triggers ferroptotic cell death in cardiomyocyte through GPX4 and Bach1/HO-1 dependent mechanisms. Our results also reveal mitochondrial iron overload via HO-1 mitochondrial translocation as a key mechanism as well as a potential molecular target for oxidative stress-induced ferroptosis in cardiomyocytes.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative
D019190 Iron Overload An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989) Overload, Iron
D032383 Myocytes, Cardiac Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC). Cardiomyocytes,Muscle Cells, Cardiac,Muscle Cells, Heart,Cardiac Muscle Cell,Cardiac Muscle Cells,Cardiac Myocyte,Cardiac Myocytes,Cardiomyocyte,Cell, Cardiac Muscle,Cell, Heart Muscle,Cells, Cardiac Muscle,Cells, Heart Muscle,Heart Muscle Cell,Heart Muscle Cells,Muscle Cell, Cardiac,Muscle Cell, Heart,Myocyte, Cardiac

Related Publications

Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
April 2019, Experimental eye research,
Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
January 2022, Frontiers in cell and developmental biology,
Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
December 2018, Experimental and therapeutic medicine,
Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
April 2021, Autophagy,
Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
November 2015, Oncotarget,
Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
August 1999, Cancer research,
Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
January 2015, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
January 2007, Annual review of pharmacology and toxicology,
Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
March 2022, Biomolecules,
Yi Chen, and Xiaoyun Guo, and Yachang Zeng, and Xiaoliang Mo, and Siqi Hong, and Hui He, and Jing Li, and Sulail Fatima, and Qinghang Liu
July 2023, Research square,
Copied contents to your clipboard!